The role of prostate inflammation and fibrosis in lower urinary tract symptoms

Wade A. Bushman, Travis Jerde

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Lower urinary tract symptoms (LUTS) in aging men are extremely common. They have historically been attributed to benign prostatic hyperplasia (BPH), enlargement of the prostate, and bladder outlet obstruction. However, recent studies have revealed acute and chronic inflammation to be highly associated with LUTS, correlated with prostatic enlargement, and implicated as a cause of prostatic fibrosis that contributes to bladder outlet obstruction. This review examines the evidence implicating inflammation and fibrosis in BPH/LUTS. It identifies potential mechanisms by which inflammation may drive nociceptive signaling as well as hyperplastic growth and fibrosis and identifies targets for pharmacological intervention. This is a promising area for research and development of novel therapies to prevent or more effectively treat LUTS in aging men.

Original languageEnglish (US)
Pages (from-to)F817-F821
JournalAmerican Journal of Physiology - Renal Physiology
Volume311
Issue number4
DOIs
StatePublished - 2016

Fingerprint

Lower Urinary Tract Symptoms
Prostate
Fibrosis
Inflammation
Urinary Bladder Neck Obstruction
Prostatic Hyperplasia
Pharmacology
Growth
Research
Therapeutics

Keywords

  • BPH
  • Fibrosis
  • Inflammation
  • Prostate

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

The role of prostate inflammation and fibrosis in lower urinary tract symptoms. / Bushman, Wade A.; Jerde, Travis.

In: American Journal of Physiology - Renal Physiology, Vol. 311, No. 4, 2016, p. F817-F821.

Research output: Contribution to journalArticle

@article{73f6598518bb459f9a4a7ea0742e3d61,
title = "The role of prostate inflammation and fibrosis in lower urinary tract symptoms",
abstract = "Lower urinary tract symptoms (LUTS) in aging men are extremely common. They have historically been attributed to benign prostatic hyperplasia (BPH), enlargement of the prostate, and bladder outlet obstruction. However, recent studies have revealed acute and chronic inflammation to be highly associated with LUTS, correlated with prostatic enlargement, and implicated as a cause of prostatic fibrosis that contributes to bladder outlet obstruction. This review examines the evidence implicating inflammation and fibrosis in BPH/LUTS. It identifies potential mechanisms by which inflammation may drive nociceptive signaling as well as hyperplastic growth and fibrosis and identifies targets for pharmacological intervention. This is a promising area for research and development of novel therapies to prevent or more effectively treat LUTS in aging men.",
keywords = "BPH, Fibrosis, Inflammation, Prostate",
author = "Bushman, {Wade A.} and Travis Jerde",
year = "2016",
doi = "10.1152/ajprenal.00602.2015",
language = "English (US)",
volume = "311",
pages = "F817--F821",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - The role of prostate inflammation and fibrosis in lower urinary tract symptoms

AU - Bushman, Wade A.

AU - Jerde, Travis

PY - 2016

Y1 - 2016

N2 - Lower urinary tract symptoms (LUTS) in aging men are extremely common. They have historically been attributed to benign prostatic hyperplasia (BPH), enlargement of the prostate, and bladder outlet obstruction. However, recent studies have revealed acute and chronic inflammation to be highly associated with LUTS, correlated with prostatic enlargement, and implicated as a cause of prostatic fibrosis that contributes to bladder outlet obstruction. This review examines the evidence implicating inflammation and fibrosis in BPH/LUTS. It identifies potential mechanisms by which inflammation may drive nociceptive signaling as well as hyperplastic growth and fibrosis and identifies targets for pharmacological intervention. This is a promising area for research and development of novel therapies to prevent or more effectively treat LUTS in aging men.

AB - Lower urinary tract symptoms (LUTS) in aging men are extremely common. They have historically been attributed to benign prostatic hyperplasia (BPH), enlargement of the prostate, and bladder outlet obstruction. However, recent studies have revealed acute and chronic inflammation to be highly associated with LUTS, correlated with prostatic enlargement, and implicated as a cause of prostatic fibrosis that contributes to bladder outlet obstruction. This review examines the evidence implicating inflammation and fibrosis in BPH/LUTS. It identifies potential mechanisms by which inflammation may drive nociceptive signaling as well as hyperplastic growth and fibrosis and identifies targets for pharmacological intervention. This is a promising area for research and development of novel therapies to prevent or more effectively treat LUTS in aging men.

KW - BPH

KW - Fibrosis

KW - Inflammation

KW - Prostate

UR - http://www.scopus.com/inward/record.url?scp=84989829659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989829659&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00602.2015

DO - 10.1152/ajprenal.00602.2015

M3 - Article

C2 - 27440781

AN - SCOPUS:84989829659

VL - 311

SP - F817-F821

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 4

ER -